STOCK TITAN

EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Edwards Lifesciences Corporation (NYSE: EW) will participate in the upcoming J.P.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Edwards Lifesciences Corporation (NYSE: EW) will participate in the upcoming J.P. Morgan Healthcare Conference on January 10, 2023. The presentation is scheduled for 11:15 a.m. PT and will be led by CEO Michael A. Mussallem, alongside Bernard Zovighian and CFO Scott Ullem. A live webcast will be available on the Edwards Lifesciences investor relations website, with an archived version accessible later that day. Edwards Lifesciences is recognized for its innovations in structural heart disease and critical care monitoring.

Loading...
Loading translation...
Argus Session date unavailable
-1.69% session move Open Argus
Details

News Market Reaction – EW

The recorded move for EW in the trading session of this news was -1.69%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

IRVINE, Calif., Jan. 5, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. 

 Michael A. Mussallem, chairman and chief executive officer, is scheduled to present at 11:15 a.m. PT.  Bernard Zovighian, president and incoming chief executive officer, and Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.  We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.  For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.  All other trademarks are the property of their respective owners.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301714286.html

SOURCE Edwards Lifesciences Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Edwards Lifesciences presenting at the J.P. Morgan Healthcare Conference?

Edwards Lifesciences will present at the J.P. Morgan Healthcare Conference on January 10, 2023.

Who will represent Edwards Lifesciences at the conference?

Michael A. Mussallem, Bernard Zovighian, and Scott Ullem will represent Edwards Lifesciences at the conference.

What time is Edwards Lifesciences' presentation at the J.P. Morgan Healthcare Conference?

The presentation by Edwards Lifesciences is scheduled for 11:15 a.m. PT.

Where can I watch the Edwards Lifesciences presentation live?

The live presentation can be viewed on the Edwards Lifesciences investor relations website.

What is the significance of the J.P. Morgan Healthcare Conference for Edwards Lifesciences?

The conference provides Edwards Lifesciences a platform to showcase its innovations and connect with stakeholders in the healthcare sector.

Keep reading